{
    "hands_on_practices": [
        {
            "introduction": "We begin our hands-on practices by exploring a classic but critical pitfall in statistical analysis: Simpson's paradox. This exercise  demonstrates how failing to account for a variable that modifies an effect—in this case, a genetic marker influencing treatment response—can lead to conclusions that are the complete opposite of the truth. By working through this example, you will see how an effect can appear harmful in an aggregated analysis, yet be beneficial within every single subgroup, underscoring the necessity of stratified analysis in the presence of effect modification.",
            "id": "4967010",
            "problem": "Consider a randomized clinical setting in which a thrombolytic treatment, denoted by $T \\in \\{0,1\\}$, is evaluated for its effect on the occurrence of intracranial hemorrhage, denoted by $Y \\in \\{0,1\\}$, where $Y=1$ indicates hemorrhage. A genetic marker $G \\in \\{0,1\\}$ is known from prior biological studies to influence baseline hemorrhage risk and the pharmacodynamics of the thrombolytic, creating potential effect modification. Assume the following scientifically plausible and internally consistent counts were observed:\n\nWithin the stratum $G=0$ (low-risk genotype): among the treated ($T=1$), $Y=1$ for $5$ out of $1000$, and among the untreated ($T=0$), $Y=1$ for $10$ out of $1000$.\n\nWithin the stratum $G=1$ (high-risk genotype): among the treated ($T=1$), $Y=1$ for $190$ out of $1000$, and among the untreated ($T=0$), $Y=1$ for $20$ out of $100$.\n\nFor clarity, the total counts by stratum are therefore: for $G=0$, treated $1000$ and untreated $1000$; for $G=1$, treated $1000$ and untreated $100$. These totals are realistic if, for example, clinicians preferentially treated those with a high-risk genotype.\n\nStarting from the foundational definitions of probability, odds $\\frac{p}{1-p}$, and the odds ratio (the ratio of odds in the treated to odds in the untreated), and using the law of total probability to form marginal quantities, address the following.\n\nFirst, demonstrate the presence of Simpson’s paradox: verify that within each stratum of $G$, the odds of $Y=1$ are lower in the treated ($T=1$) than in the untreated ($T=0$), yet when aggregating across strata and ignoring $G$, the marginal odds ratio indicates a harmful association of treatment with $Y$.\n\nSecond, formalize how stratified analysis resolves the apparent reversal by estimating a common stratum-adjusted odds ratio using the Mantel–Haenszel (MH) approach, defined as the conventional stratum-weighted estimator for a common odds ratio across strata.\n\nFinally, compute the numerical value of the difference between the marginal log odds ratio that ignores $G$ and the Mantel–Haenszel log odds ratio that stratifies by $G$; that is, compute $\\ln(\\text{OR}_{\\text{marginal}}) - \\ln(\\text{OR}_{\\text{MH}})$ based on the above counts. Round your answer to four significant figures. No units are required.",
            "solution": "The problem is validated as scientifically grounded, well-posed, objective, and internally consistent. It presents a classic scenario of Simpson's paradox in medical statistics and asks for a standard, verifiable analysis.\n\nLet $T$ denote the treatment ($T=1$ for treated, $T=0$ for untreated), $Y$ the outcome ($Y=1$ for hemorrhage, $Y=0$ for no hemorrhage), and $G$ the genetic marker ($G=0$ for low-risk, $G=1$ for high-risk). The odds of an event are defined as $\\frac{p}{1-p}$, where $p$ is the probability of the event. The odds ratio (OR) is the ratio of the odds of the event in the treated group to the odds in the untreated group.\n\nFirst, we will demonstrate Simpson's paradox by calculating the stratum-specific and marginal odds ratios.\n\nFor a generic $2 \\times 2$ table of counts:\n\\begin{array}{c|cc|c}\n & Y=1 & Y=0 & \\text{Total} \\\\\n\\hline\nT=1 & a & b & a+b \\\\\nT=0 & c & d & c+d\n\\end{array}\nThe odds ratio is calculated as $\\text{OR} = \\frac{a/b}{c/d} = \\frac{ad}{bc}$.\n\nAnalysis within Stratum $G=0$ (low-risk):\nThe data for $G=0$ are:\n- Treated ($T=1$): $5$ events ($Y=1$) and $1000-5=995$ non-events ($Y=0$). So, $a_0 = 5$, $b_0 = 995$.\n- Untreated ($T=0$): $10$ events ($Y=1$) and $1000-10=990$ non-events ($Y=0$). So, $c_0 = 10$, $d_0 = 990$.\n\nThe odds of hemorrhage for the treated are $\\text{Odds}(Y=1|T=1, G=0) = \\frac{a_0}{b_0} = \\frac{5}{995}$.\nThe odds of hemorrhage for the untreated are $\\text{Odds}(Y=1|T=0, G=0) = \\frac{c_0}{d_0} = \\frac{10}{990}$.\n\nThe odds ratio for the $G=0$ stratum is:\n$$ \\text{OR}_{G=0} = \\frac{a_0 d_0}{b_0 c_0} = \\frac{5 \\times 990}{995 \\times 10} = \\frac{4950}{9950} = \\frac{99}{199} \\approx 0.4975 $$\nSince $\\text{OR}_{G=0} < 1$, the treatment appears to be protective against hemorrhage in this stratum.\n\nAnalysis within Stratum $G=1$ (high-risk):\nThe data for $G=1$ are:\n- Treated ($T=1$): $190$ events ($Y=1$) and $1000-190=810$ non-events ($Y=0$). So, $a_1 = 190$, $b_1 = 810$.\n- Untreated ($T=0$): $20$ events ($Y=1$) and $100-20=80$ non-events ($Y=0$). So, $c_1 = 20$, $d_1 = 80$.\n\nThe odds of hemorrhage for the treated are $\\text{Odds}(Y=1|T=1, G=1) = \\frac{a_1}{b_1} = \\frac{190}{810}$.\nThe odds of hemorrhage for the untreated are $\\text{Odds}(Y=1|T=0, G=1) = \\frac{c_1}{d_1} = \\frac{20}{80}$.\n\nThe odds ratio for the $G=1$ stratum is:\n$$ \\text{OR}_{G=1} = \\frac{a_1 d_1}{b_1 c_1} = \\frac{190 \\times 80}{810 \\times 20} = \\frac{15200}{16200} = \\frac{76}{81} \\approx 0.9383 $$\nSince $\\text{OR}_{G=1} < 1$, the treatment also appears to be protective in this stratum, although the effect is weaker.\n\nMarginal (Aggregated) Analysis, Ignoring $G$:\nTo find the marginal odds ratio, we first aggregate the counts across the strata of $G$.\n- Total Treated ($T=1$): $a = a_0 + a_1 = 5 + 190 = 195$ events. $b = b_0 + b_1 = 995 + 810 = 1805$ non-events.\n- Total Untreated ($T=0$): $c = c_0 + c_1 = 10 + 20 = 30$ events. $d = d_0 + d_1 = 990 + 80 = 1070$ non-events.\n\nThe marginal $2 \\times 2$ table is:\n\\begin{array}{c|cc|c}\n & Y=1 & Y=0 & \\text{Total} \\\\\n\\hline\nT=1 & 195 & 1805 & 2000 \\\\\nT=0 & 30 & 1070 & 1100\n\\end{array}\nThe marginal odds ratio is:\n$$ \\text{OR}_{\\text{marginal}} = \\frac{ad}{bc} = \\frac{195 \\times 1070}{1805 \\times 30} = \\frac{208650}{54150} = \\frac{1391}{361} \\approx 3.853 $$\nSince $\\text{OR}_{\\text{marginal}} > 1$, the aggregated analysis suggests that the treatment is harmful. This confirms the presence of Simpson's paradox: the association is protective within each stratum of $G$ ($\\text{OR}_{G=0} < 1$ and $\\text{OR}_{G=1} < 1$) but reverses direction and appears harmful when the strata are combined ($\\text{OR}_{\\text{marginal}} > 1$). This reversal is due to confounding by $G$, as the high-risk group ($G=1$) was preferentially treated.\n\nSecond, we formalize and compute the Mantel–Haenszel (MH) odds ratio. The MH method provides a summary odds ratio adjusted for the confounding variable $G$, assuming a common odds ratio across strata. For $k$ strata, indexed by $i=1, \\dots, k$, with counts $(a_i, b_i, c_i, d_i)$ and total subjects $N_i = a_i+b_i+c_i+d_i$ in stratum $i$, the MH estimator is:\n$$ \\text{OR}_{\\text{MH}} = \\frac{\\sum_{i=1}^{k} \\frac{a_i d_i}{N_i}}{\\sum_{i=1}^{k} \\frac{b_i c_i}{N_i}} $$\nFor our problem, we have two strata ($i=0, 1$).\nStratum $G=0$: $a_0 = 5, b_0 = 995, c_0 = 10, d_0 = 990$. Total $N_0 = 5+995+10+990 = 2000$.\nStratum $G=1$: $a_1 = 190, b_1 = 810, c_1 = 20, d_1 = 80$. Total $N_1 = 190+810+20+80 = 1100$.\n\nThe numerator of $\\text{OR}_{\\text{MH}}$ is:\n$$ \\sum_{i=0}^{1} \\frac{a_i d_i}{N_i} = \\frac{a_0 d_0}{N_0} + \\frac{a_1 d_1}{N_1} = \\frac{5 \\times 990}{2000} + \\frac{190 \\times 80}{1100} = \\frac{4950}{2000} + \\frac{15200}{1100} = 2.475 + \\frac{152}{11} $$\nThe denominator of $\\text{OR}_{\\text{MH}}$ is:\n$$ \\sum_{i=0}^{1} \\frac{b_i c_i}{N_i} = \\frac{b_0 c_0}{N_0} + \\frac{b_1 c_1}{N_1} = \\frac{995 \\times 10}{2000} + \\frac{810 \\times 20}{1100} = \\frac{9950}{2000} + \\frac{16200}{1100} = 4.975 + \\frac{162}{11} $$\nLet's use common denominators to be precise:\n$$ \\sum \\frac{a_i d_i}{N_i} = \\frac{99}{40} + \\frac{152}{11} = \\frac{99 \\times 11 + 152 \\times 40}{440} = \\frac{1089 + 6080}{440} = \\frac{7169}{440} $$\n$$ \\sum \\frac{b_i c_i}{N_i} = \\frac{199}{40} + \\frac{162}{11} = \\frac{199 \\times 11 + 162 \\times 40}{440} = \\frac{2189 + 6480}{440} = \\frac{8669}{440} $$\nSo, the Mantel-Haenszel odds ratio is:\n$$ \\text{OR}_{\\text{MH}} = \\frac{7169/440}{8669/440} = \\frac{7169}{8669} \\approx 0.8271 $$\nThis adjusted odds ratio is less than $1$, reflecting the protective effect seen within the strata, thus resolving the paradox.\n\nFinally, we compute the required difference, $\\ln(\\text{OR}_{\\text{marginal}}) - \\ln(\\text{OR}_{\\text{MH}})$.\nUsing the exact fractional forms:\n$\\text{OR}_{\\text{marginal}} = \\frac{1391}{361}$\n$\\text{OR}_{\\text{MH}} = \\frac{7169}{8669}$\n\nThe quantity to compute is:\n$$ \\ln(\\text{OR}_{\\text{marginal}}) - \\ln(\\text{OR}_{\\text{MH}}) = \\ln\\left(\\frac{\\text{OR}_{\\text{marginal}}}{\\text{OR}_{\\text{MH}}}\\right) $$\n$$ = \\ln\\left(\\frac{1391/361}{7169/8669}\\right) = \\ln\\left(\\frac{1391 \\times 8669}{361 \\times 7169}\\right) $$\nNow we use numerical values for calculation:\n$$ \\text{OR}_{\\text{marginal}} \\approx 3.8531856 $$\n$$ \\text{OR}_{\\text{MH}} \\approx 0.8270850 $$\n$$ \\ln(\\text{OR}_{\\text{marginal}}) \\approx \\ln(3.8531856) \\approx 1.34888 $$\n$$ \\ln(\\text{OR}_{\\text{MH}}) \\approx \\ln(0.8270850) \\approx -0.18983 $$\nThe difference is:\n$$ \\ln(\\text{OR}_{\\text{marginal}}) - \\ln(\\text{OR}_{\\text{MH}}) \\approx 1.34888 - (-0.18983) = 1.34888 + 0.18983 = 1.53871 $$\nRounding to four significant figures, the result is $1.539$.\nThis value represents the magnitude of confounding by $G$ on the log-odds ratio scale.",
            "answer": "$$\\boxed{1.539}$$"
        },
        {
            "introduction": "Having established the critical importance of identifying effect modification, we now turn to the nuances of its measurement. The concept of interaction is not absolute; its presence, direction, and magnitude depend fundamentally on the chosen statistical scale—typically additive or multiplicative. This practice  will guide you through calculating two key epidemiological measures, the Relative Excess Risk due to Interaction (RERI) for the additive scale and the ratio of risk ratios for the multiplicative scale, revealing how the same data can simultaneously suggest synergy on one scale and antagonism on the other.",
            "id": "4966962",
            "problem": "A cohort study investigates the one-year risk of a severe renal complication ($Y=1$) among patients with hypertension. Two binary exposures are considered: smoking ($X \\in \\{0,1\\}$) and poor glycemic control ($Z \\in \\{0,1\\}$). Let $p_{xz} = \\Pr(Y=1 \\mid X=x, Z=z)$ denote the risk for each exposure combination, and let the risk ratio relative to the unexposed group be $RR_{xz} = p_{xz}/p_{00}$ for $(x,z) \\in \\{0,1\\}^{2}$. Assume that the baseline risk is $p_{00} = 0.05$, and the observed risk ratios are $RR_{10} = 2.0$, $RR_{01} = 3.0$, and $RR_{11} = 4.5$.\n\nStarting from the fundamental definitions of risk, risk difference, and the concept of additive interaction as departure from additivity of risks, derive the expression for the Relative Excess Risk due to Interaction (RERI) in terms of $p_{xz}$ and then in terms of $RR_{xz}$. Use the provided values to compute the numerical value of RERI. Additionally, assess multiplicative interaction by comparing $RR_{11}$ with $RR_{10} \\cdot RR_{01}$ to determine whether the joint effect is sub-multiplicative or supra-multiplicative.\n\nYour final reported answer must be the numerical value of RERI. No rounding is required. Express the final answer without any units.",
            "solution": "The problem is subjected to validation.\n\n### Step 1: Extract Givens\n-   The outcome variable is a binary indicator for a severe renal complication: $Y \\in \\{0, 1\\}$.\n-   The exposures are two binary variables: smoking, $X \\in \\{0, 1\\}$, and poor glycemic control, $Z \\in \\{0, 1\\}$.\n-   The risk for a given exposure combination is defined as $p_{xz} = \\Pr(Y=1 \\mid X=x, Z=z)$.\n-   The risk ratio relative to the unexposed group (X=0, Z=0) is $RR_{xz} = p_{xz}/p_{00}$.\n-   The baseline risk (unexposed to both factors) is $p_{00} = 0.05$.\n-   The observed risk ratios are $RR_{10} = 2.0$ (smoking only), $RR_{01} = 3.0$ (poor glycemic control only), and $RR_{11} = 4.5$ (both exposures).\n-   The tasks are to derive the expression for the Relative Excess Risk due to Interaction (RERI), compute its numerical value, and assess multiplicative interaction.\n\n### Step 2: Validate Using Extracted Givens\n-   **Scientifically Grounded**: The problem is grounded in the standard epidemiological framework for assessing interaction between exposures. The concepts of risk, risk ratio, additive interaction (measured by RERI), and multiplicative interaction are fundamental and well-defined in biostatistics and epidemiology.\n-   **Well-Posed**: The problem is well-posed. It provides clear definitions and all necessary numerical values to perform the required derivations and calculations. A unique and stable solution exists.\n-   **Objective**: The problem is stated in objective, quantitative terms, free of any subjective or ambiguous language.\n-   **Completeness and Consistency**: The problem is self-contained and internally consistent. The provided values are plausible and do not lead to any contradictions.\n-   **Realism**: The context (hypertension, smoking, glycemic control, and renal complications) is medically realistic, and the risk ratio values are within a plausible range for such a study.\n\n### Step 3: Verdict and Action\nThe problem is valid. A full solution will be provided.\n\n### Solution Derivation\n\nThe analysis of interaction between two exposures, $X$ and $Z$, on a binary outcome $Y$ can be conducted on an additive scale or a multiplicative scale. The problem requires an assessment on both scales.\n\nFirst, we define the excess risk. For a given exposure, the excess risk is the risk in the exposed group minus the risk in the unexposed (baseline) group. This is also known as the risk difference ($RD$).\n-   Excess risk for exposure $X$ alone: $ER_{10} = p_{10} - p_{00}$.\n-   Excess risk for exposure $Z$ alone: $ER_{01} = p_{01} - p_{00}$.\n-   Excess risk for both exposures $X$ and $Z$: $ER_{11} = p_{11} - p_{00}$.\n\nAdditive interaction is defined as a departure from the additivity of individual excess risks. If there were no additive interaction, the excess risk from the combined exposure would be equal to the sum of the excess risks from each exposure individually.\nExpected excess risk under additivity: $ER_{10} + ER_{01}$.\nThe observed excess risk in the doubly exposed group is $ER_{11}$.\n\nThe degree of additive interaction is quantified by the Interaction Contrast ($IC$), which is the difference between the observed joint excess risk and the expected joint excess risk under additivity.\n$$IC = ER_{11} - (ER_{10} + ER_{01})$$\nSubstituting the definitions of excess risk:\n$$IC = (p_{11} - p_{00}) - [(p_{10} - p_{00}) + (p_{01} - p_{00})]$$\n$$IC = p_{11} - p_{00} - p_{10} + p_{00} - p_{01} + p_{00}$$\n$$IC = p_{11} - p_{10} - p_{01} + p_{00}$$\n\nThe Relative Excess Risk due to Interaction (RERI) is a standardized measure of additive interaction. It is defined as the Interaction Contrast divided by the baseline risk, $p_{00}$. This normalizes the interaction measure, making it a relative measure. This is the first part of the derivation as requested, expressing RERI in terms of $p_{xz}$.\n$$RERI = \\frac{IC}{p_{00}} = \\frac{p_{11} - p_{10} - p_{01} + p_{00}}{p_{00}}$$\n\nTo derive the expression for RERI in terms of risk ratios ($RR_{xz}$), we divide each term in the numerator by $p_{00}$:\n$$RERI = \\frac{p_{11}}{p_{00}} - \\frac{p_{10}}{p_{00}} - \\frac{p_{01}}{p_{00}} + \\frac{p_{00}}{p_{00}}$$\nBy the definition $RR_{xz} = p_{xz}/p_{00}$, we can substitute these terms. Note that $RR_{00} = p_{00}/p_{00} = 1$.\n$$RERI = RR_{11} - RR_{10} - RR_{01} + 1$$\nThis is the standard formula for RERI in terms of risk ratios. The absence of additive interaction corresponds to $RERI = 0$. A positive RERI ($RERI>0$) indicates positive additive interaction (synergy), and a negative RERI ($RERI<0$) indicates negative additive interaction (antagonism).\n\nNow, we compute the numerical value of RERI using the given risk ratios: $RR_{10} = 2.0$, $RR_{01} = 3.0$, and $RR_{11} = 4.5$.\n$$RERI = 4.5 - 2.0 - 3.0 + 1$$\n$$RERI = 4.5 - 5.0 + 1$$\n$$RERI = -0.5 + 1$$\n$$RERI = 0.5$$\nSince $RERI = 0.5 > 0$, there is evidence of a positive additive interaction, or synergy on the additive scale. The interaction accounts for an excess risk of $0.5$ times the baseline risk.\n\nNext, we assess for multiplicative interaction. Interaction on the multiplicative scale is absent if the joint risk ratio equals the product of the individual risk ratios.\nCondition for no multiplicative interaction: $RR_{11} = RR_{10} \\times RR_{01}$.\n-   If $RR_{11} > RR_{10} \\times RR_{01}$, the interaction is supra-multiplicative (synergistic).\n-   If $RR_{11} < RR_{10} \\times RR_{01}$, the interaction is sub-multiplicative (antagonistic).\n\nWe are given $RR_{10} = 2.0$, $RR_{01} = 3.0$, and $RR_{11} = 4.5$.\nFirst, calculate the product of the individual risk ratios:\n$$RR_{10} \\times RR_{01} = 2.0 \\times 3.0 = 6.0$$\nNow, compare this product to the observed joint risk ratio, $RR_{11}$:\n$$4.5 < 6.0$$\nSince $RR_{11} < RR_{10} \\times RR_{01}$, the joint effect is sub-multiplicative. This means that the combined effect of smoking and poor glycemic control is less than what would be predicted by multiplying their individual effects.\n\nIt is noteworthy that the exposures exhibit synergistic interaction on the additive scale ($RERI > 0$) but antagonistic interaction on the multiplicative scale ($RR_{11} < RR_{10} \\cdot RR_{01}$). This is a common finding in epidemiology and highlights the importance of specifying the scale (additive or multiplicative) on which interaction is being assessed.\n\nThe final answer required is the numerical value of RERI.",
            "answer": "$$\\boxed{0.5}$$"
        },
        {
            "introduction": "Our final practice transitions from describing interaction to performing formal statistical inference. While visual inspection and calculating various metrics are vital, a key task in modeling is to test whether an observed interaction is statistically significant or likely due to chance. This exercise  introduces the likelihood ratio test as a powerful tool for comparing nested models—one with and one without an interaction term—allowing you to formally test the null hypothesis of no effect modification on the log-odds scale.",
            "id": "4966951",
            "problem": "A multicenter randomized controlled trial investigates whether a pharmacologic treatment modifies the effect of a genetic variant on the 30-day incidence of acute kidney injury in hospitalized patients. Let $Y_{i} \\in \\{0,1\\}$ denote the binary outcome for patient $i$, with $Y_{i}=1$ indicating acute kidney injury by day $30$. Let $T_{i} \\in \\{0,1\\}$ denote allocation to the active treatment ($1$) versus usual care ($0$), and $G_{i} \\in \\{0,1\\}$ denote carriage of a specific loss-of-function allele ($1$) versus non-carriage ($0$). Let $\\mathbf{X}_{i}$ contain baseline covariates (e.g., age and estimated glomerular filtration rate), modeled additively.\n\nAssume independent observations and a correctly specified logistic regression model with the Bernoulli likelihood. Consider two nested models for the log-odds:\n- Reduced model (no interaction): $\\log\\left(\\frac{p_{i}}{1-p_{i}}\\right) = \\alpha_{0} + \\alpha_{1} T_{i} + \\alpha_{2} G_{i} + \\boldsymbol{\\alpha}_{c}^{\\top}\\mathbf{X}_{i}$.\n- Full model (with interaction): $\\log\\left(\\frac{p_{i}}{1-p_{i}}\\right) = \\beta_{0} + \\beta_{1} T_{i} + \\beta_{2} G_{i} + \\beta_{3} (T_{i}G_{i}) + \\boldsymbol{\\beta}_{c}^{\\top}\\mathbf{X}_{i}$.\n\nYou are provided the maximized log-likelihoods from fitting these models to the trial data:\n- Reduced model maximized log-likelihood: $\\ell_{\\text{reduced}} = -1187.50$.\n- Full model maximized log-likelihood: $\\ell_{\\text{full}} = -1185.50$.\n\nStarting from the definition of the likelihood for independent Bernoulli outcomes and the principle of comparing nested models, derive the likelihood ratio test for testing the null hypothesis $H_{0}\\!:\\,\\beta_{3}=0$ (no effect modification on the log-odds scale). Using the provided maximized log-likelihoods, evaluate the corresponding test statistic and justify, under large-sample conditions, that its null distribution converges to a chi-square distribution with one degree of freedom. Compute the asymptotic $p$-value associated with this test statistic under the one-degree-of-freedom chi-square limit and briefly interpret the result in terms of evidence for effect modification.\n\nAnswer specification: Express the final $p$-value as a decimal and round your answer to three significant figures.",
            "solution": "The problem asks for the derivation and application of the likelihood ratio test (LRT) to assess for effect modification in a logistic regression context.\n\nFirst, we validate the problem statement.\n\n**Step 1: Extract Givens**\n- Outcome: $Y_{i} \\in \\{0,1\\}$, with $Y_{i}=1$ for acute kidney injury.\n- Predictors: $T_{i} \\in \\{0,1\\}$ for treatment (active=1), $G_{i} \\in \\{0,1\\}$ for genetic variant (carrier=1).\n- Covariates: $\\mathbf{X}_{i}$, modeled additively.\n- Assumptions: Independent observations, correctly specified logistic regression model with the Bernoulli likelihood.\n- Reduced model (no interaction): $\\log\\left(\\frac{p_{i}}{1-p_{i}}\\right) = \\alpha_{0} + \\alpha_{1} T_{i} + \\alpha_{2} G_{i} + \\boldsymbol{\\alpha}_{c}^{\\top}\\mathbf{X}_{i}$.\n- Full model (with interaction): $\\log\\left(\\frac{p_{i}}{1-p_{i}}\\right) = \\beta_{0} + \\beta_{1} T_{i} + \\beta_{2} G_{i} + \\beta_{3} (T_{i}G_{i}) + \\boldsymbol{\\beta}_{c}^{\\top}\\mathbf{X}_{i}$.\n- Maximized log-likelihood for the reduced model: $\\ell_{\\text{reduced}} = -1187.50$.\n- Maximized log-likelihood for the full model: $\\ell_{\\text{full}} = -1185.50$.\n- Null hypothesis: $H_{0}\\!:\\,\\beta_{3}=0$.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded, being a standard application of statistical theory (logistic regression, likelihood ratio test) to a common problem in medical research (analysis of clinical trial data, assessment of effect modification). It is well-posed, providing all necessary numerical values and model specifications to perform the requested calculations. The language is objective and precise. The problem is self-contained and internally consistent; the reduced model is correctly specified as being nested within the full model, which is the necessary condition for the LRT. The provided log-likelihood values are plausible, with $\\ell_{\\text{full}} \\ge \\ell_{\\text{reduced}}$, as must be the case since the full model is a less constrained optimization problem. The problem is therefore valid.\n\n**Step 3: Verdict and Action**\nThe problem is valid. The solution proceeds.\n\nThe likelihood function for a sample of $n$ independent patients, each with a Bernoulli outcome $Y_i$, is the product of the individual probability mass functions:\n$$L(\\boldsymbol{\\theta}) = \\prod_{i=1}^{n} P(Y_i=y_i) = \\prod_{i=1}^{n} p_i^{y_i} (1 - p_i)^{1-y_i}$$\nwhere $p_i = P(Y_i=1)$ and $\\boldsymbol{\\theta}$ represents the vector of model parameters. The log-likelihood function is:\n$$\\ell(\\boldsymbol{\\theta}) = \\log(L(\\boldsymbol{\\theta})) = \\sum_{i=1}^{n} \\left[ y_i \\log(p_i) + (1 - y_i) \\log(1 - p_i) \\right]$$\nThe logistic model links $p_i$ to the covariates via the logit function: $\\text{logit}(p_i) = \\log\\left(\\frac{p_i}{1-p_i}\\right) = \\mathbf{Z}_i^{\\top}\\boldsymbol{\\theta}$, where $\\mathbf{Z}_i$ is the design vector for patient $i$.\n\nThe likelihood ratio test is used to compare two nested models. The reduced model is nested within the full model because it can be obtained by imposing a constraint on the parameters of the full model. Here, the reduced model is equivalent to the full model under the single linear constraint $H_{0}\\!:\\,\\beta_{3}=0$.\n\nLet $\\hat{\\boldsymbol{\\theta}}_{\\text{full}}$ be the maximum likelihood estimate of the parameters for the full model, and $\\hat{\\boldsymbol{\\theta}}_{\\text{reduced}}$ be the maximum likelihood estimate for the reduced model. The corresponding maximized log-likelihoods are $\\ell_{\\text{full}} = \\ell(\\hat{\\boldsymbol{\\theta}}_{\\text{full}})$ and $\\ell_{\\text{reduced}} = \\ell(\\hat{\\boldsymbol{\\theta}}_{\\text{reduced}})$. The likelihood ratio test statistic, often denoted by $D$ or $\\Lambda_{LR}$, is defined as:\n$$D = 2 \\left( \\ell_{\\text{full}} - \\ell_{\\text{reduced}} \\right)$$\nThis statistic quantifies the improvement in model fit (as measured by the log-likelihood) from relaxing the null hypothesis constraints (i.e., moving from the reduced to the full model). Since the full model has more parameters (or, more precisely, fewer constraints), its maximized log-likelihood will always be greater than or equal to that of the reduced model, so $D \\ge 0$.\n\nUsing the provided values:\n$$D = 2 \\left( (-1185.50) - (-1187.50) \\right)$$\n$$D = 2 \\left( -1185.50 + 1187.50 \\right)$$\n$$D = 2 \\left( 2.00 \\right)$$\n$$D = 4.00$$\n\nAccording to Wilks' theorem, under the null hypothesis ($H_0$) and for a sufficiently large sample size, the distribution of the likelihood ratio test statistic $D$ converges to a chi-square ($\\chi^2$) distribution. The degrees of freedom ($df$) for this $\\chi^2$ distribution is equal to the number of independent parameters that are fixed under the null hypothesis. This is the difference in the number of free parameters between the full and reduced models.\n\nIn this problem, the full model has parameters $\\{\\beta_{0}, \\beta_{1}, \\beta_{2}, \\beta_{3}, \\boldsymbol{\\beta}_{c}\\}$. The reduced model has parameters $\\{\\alpha_{0}, \\alpha_{1}, \\alpha_{2}, \\boldsymbol{\\alpha}_{c}\\}$, which is equivalent to the full model with the single constraint $\\beta_{3}=0$. Therefore, the difference in the number of parameters is $1$. The degrees of freedom for the null distribution is $df=1$.\nThus, under $H_0:\\beta_3=0$, the test statistic $D$ asymptotically follows a $\\chi^2_1$ distribution.\n\nThe $p$-value is the probability of observing a test statistic value at least as extreme as the one calculated ($D=4.00$), assuming the null hypothesis is true.\n$$p\\text{-value} = P(\\chi^2_1 \\geq 4.00)$$\nA chi-square distribution with one degree of freedom is the distribution of the square of a standard normal random variable, $Z \\sim N(0,1)$. So, $\\chi^2_1 \\sim Z^2$.\nTherefore, the $p$-value can be calculated as:\n$$P(\\chi^2_1 \\geq 4.00) = P(Z^2 \\geq 4.00) = P(|Z| \\geq \\sqrt{4.00}) = P(|Z| \\geq 2)$$\nThis is the two-tailed probability for a standard normal variable to be outside the interval $[-2, 2]$.\n$$P(|Z| \\geq 2) = P(Z \\leq -2) + P(Z \\geq 2) = 2 \\times P(Z \\leq -2)$$\nUsing a standard normal cumulative distribution function, $\\Phi(-2) \\approx 0.02275$.\n$$p\\text{-value} = 2 \\times 0.02275 = 0.0455$$\nRounding to three significant figures, the $p$-value is $0.0455$.\n\nBrief interpretation: The calculated $p$-value is $0.0455$. Conventionally, using a significance level of $\\alpha=0.05$, this result is statistically significant ($p < 0.05$). We would reject the null hypothesis $H_0: \\beta_3=0$. This indicates there is statistically significant evidence for an interaction between the treatment and the genetic variant. In other words, the effect of the pharmacologic treatment on the log-odds of developing acute kidney injury appears to be modified by the presence of the loss-of-function allele. The magnitude and direction of the treatment effect differ between carriers and non-carriers of the allele.",
            "answer": "$$ \\boxed{0.0455} $$"
        }
    ]
}